Nancy Valente

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Valente:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xencor Inc EVP, Chief Development Officer Common Stock 49.2K $542K $11.03 02 May 2025 Direct
Myovant Sciences Ltd. Director Common Shares 0 $27.00 10 Mar 2023 Direct
Myovant Sciences Ltd. Director Stock Options (Right to Buy) 0 10 Mar 2023 Direct

Insider Reports Filed by Nancy Valente

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XNCR Xencor Inc 02 May 2025 1 -$50.9K 4 EVP, Chief Development Officer 06 May 2025, 16:40
XNCR Xencor Inc 10 Mar 2025 1 -$34.9K 4 EVP, Chief Development Officer 11 Mar 2025, 16:28
XNCR Xencor Inc 02 May 2024 1 -$112K 4 EVP, Chief Development Officer 03 May 2024, 16:06
XNCR Xencor Inc 05 Mar 2024 2 $0 4 EVP, Chief Development Officer 07 Mar 2024, 16:09
XNCR Xencor Inc 01 May 2023 2 $0 4 EVP, Chief Development Officer 03 May 2023, 20:48
MYOV Myovant Sciences Ltd. 10 Mar 2023 2 $0 4 Director 10 Mar 2023, 08:32
MYOV Myovant Sciences Ltd. 26 Oct 2022 1 $0 4 Director 28 Oct 2022, 16:34
XNCR Xencor Inc 08 Sep 2022 1 $0 4 Director 09 Sep 2022, 16:22
XNCR Xencor Inc 08 Sep 2022 0 $0 3 Director 09 Sep 2022, 16:11
MYOV Myovant Sciences Ltd. 05 Nov 2021 1 $0 4 Director 09 Nov 2021, 16:15
MYOV Myovant Sciences Ltd. 05 Nov 2021 0 $0 3 Director 09 Nov 2021, 16:13